The Food and Drug Administration has approved Menostar which is used to prevent osteoporosis. It is a transdermal patch that delivers very low doses of oestrogen daily. Tests show that it does not preclude endometrial or other cancers and increased spine bone mineral density by 2.6% over 2 years.
Source: summary of medical news story as reported by Berlex
About: FDA approves new osteoporosis drug
Date: 9 June 2004
Source: Berlex
URL:
http:/ What do you think about the features of this website?
Take our user survey and have your say:
Tools & Services:
Medical Articles:
» Next page: FDA approves new pulmonary arterial hypertension drug
Rate This Website
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
